196300 fundamentals
Key facts
HLB Pep Co., Ltd. engages in the development and production of therapeutic peptides. It operates through the following business divisions: Medicinal Peptide Materials, Research Peptide Materials, and Product and Technology Fees. The Medicinal Peptide Materials division includes leuprolin, desmopressin, and clinical peptides. The Research Peptide Materials division offers custom peptides for research and development. The Product and Technology Fees division deals with chemical library. The company was founded on May 2, 2000 and is headquartered in Gwangju, South Korea.
Valuation
Fundamental metrics to determine fair value of the stock
Growth and Profitability
Company’s recent performance and margins
Dividends
Dividend yield, history and sustainability
Financial health
Financial position and solvency of the company